DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 149 (1-2), 125-134
- https://doi.org/10.1016/s0304-3835(99)00349-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 29 references indexed in Scilit:
- Prognostic significance of pS2 protein expression in pulmonary adenocarcinomaEuropean Journal Of Cancer, 1994
- Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumorsInternational Journal of Cancer, 1994
- pS2 protein in gastric carcinoma and normal gastric mucosa: Association with clinicopathological parameters and patient survivalThe Journal of Pathology, 1993
- Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel diseaseGastroenterology, 1993
- Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990
- A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)FEBS Letters, 1989
- Breast Cancer-Associated pS2 Protein: Synthesis and Secretion by Normal Stomach MucosaScience, 1988
- Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7Nucleic Acids Research, 1984
- Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell lineNucleic Acids Research, 1982